Tenaya Therapeutics, Inc.
TNYA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $121,295 | $239,067 | $90,095 | $782,472 |
| - Cash | $4,323 | $45,681 | $95,272 | $38,129 |
| + Debt | $13,608 | $12,424 | $15,099 | $13,707 |
| Enterprise Value | $130,580 | $205,810 | $9,922 | $758,050 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$8,468 | -$8,687 | -$8,713 | -$4,025 |
| % Margin | – | – | – | – |
| EBITDA | -$102,661 | -$115,397 | -$114,952 | -$68,696 |
| % Margin | – | – | – | – |
| Net Income | -$111,129 | -$124,084 | -$123,665 | -$72,721 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.31 | -1.68 | -2.76 | -1.69 |
| % Growth | 22% | 39.1% | -63.3% | – |
| Operating Cash Flow | -$90,501 | -$102,072 | -$104,424 | -$60,812 |
| Capital Expenditures | -$1,025 | -$1,239 | -$20,630 | -$25,121 |
| Free Cash Flow | -$91,526 | -$103,311 | -$125,054 | -$85,933 |